There were no significant differences between the groups regarding insulin substitution, oral antidiabetic drugs, or physical activity at baseline or follow-up that would explain the increase in HbA1c within the observation period in the SDB PAP group (Supplementary Table 1). The gene discussed is INS; the disease is sleep apnea syndrome.